Journal article icon

Journal article

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.

Abstract:

AIMS: A detailed assessment of ophthalmic effects of an HMG CoA reductase inhibitor, simvastatin, was performed. METHODS: Six hundred and twenty one individuals considered to be at increased risk of coronary heart disease were randomised, following an 8 week placebo 'run in' period, to receive 40 mg daily simvastatin, 20 mg daily simvastatin, or matching placebo. Patients with a baseline corrected visual acuity better than 6/24 and without a history of cataract were eligible for detailed opht...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/bjo.79.11.996

Authors


Harris, ML More by this author
Wallendszus, KR More by this author
Expand authors...
Journal:
The British journal of ophthalmology
Volume:
79
Issue:
11
Pages:
996-1002
Publication date:
1995-11-05
DOI:
EISSN:
1468-2079
ISSN:
0007-1161
URN:
uuid:149eab64-57e2-4510-8db7-4cbe685199fa
Source identifiers:
49375
Local pid:
pubs:49375

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP